Dr. Hearn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
Cleveland Clinic FoundationResidency, Internal Medicine, 2010 - 2015- Cleveland Clinic FoundationResidency, Radiation Oncology, 2010 - 2015
Harvard Medical SchoolClass of 2010
Certifications & Licensure
MI State Medical License 2015 - 2025
OH State Medical License 2010 - 2015- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 100 citationsHSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort studyJason W.D. Hearn, Ghada AbuAli, Chad A. Reichard, Chandana A. Reddy, Cristina Magi-Galluzzi
The Lancet. Oncology. 2016-10-01 - 27 citationsThe Special Medical Physics Consult Process for Reirradiation Patients.Kelly C. Paradis, Charles S. Mayo, Dawn Owen, Daniel E. Spratt, Jason W.D. Hearn
Advances in Radiation Oncology. 2019-06-08 - 12 citationsTrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results.Daniela Wittmann, Akanksha Mehta, Sharon L Bober, Ziwei Zhu, Stephanie Daignault-Newton
Cancer. 2022-04-01
Press Mentions
Radiation Therapy for Oligometastatic Renal Cell Carcinoma PromisingNovember 9th, 2021
ASCO 2019: HSD3B1 and OS in Men with Low-Volume Metastatic Prostate Cancer Treated with ADT or Chemohormonal Therapy in the CHAARTED Randomized TrialJune 5th, 2019- Safely Delivering Radiation to Cancer Patients in a 'FLASH'December 4th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
